Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Quality Systems, Inc.    QSII

Delayed Quote. Delayed  - 10/24 10:00:00 pm
12.12 USD   +2.19%
10/15 NEXTGEN HEALTHC : to Help Clients Transition to Value-Based Care and..
10/12 QUALITY SYSTEMS : to Host Fiscal 2017 Second Quarter Results Confere..
08/30 QUALITY SYSTEMS : to Present at the Robert W. Baird 2016 Healthcare ..
News SummaryMost relevantAll newsSector news 

Quality Systems, Inc. : to Present at 11th Annual JMP Securities Research Conference

share with twitter share with LinkedIn share with facebook
share via e-mail
05/08/2012 | 11:05am CEST

Quality Systems, Inc. (NASDAQ: QSII) announced today that its management plans to present its corporate story at the 11th Annual JMP Securities Research Conference.

The conference, which will showcase more than 250 publicly traded and privately held companies across the technology, healthcare, financial services, real estate and consumer sectors for institutional investors, is scheduled for Monday, May 14, 2102 through Wednesday, May 16, 2012, at The Ritz-Carlton, San Francisco.

Quality Systems' Chief Financial Officer Paul A. Holt is scheduled to present on Monday, May 14, 2012, at 11:00 A.M. local time. The presentation will address the company's operations and strategy. Each participating company is scheduled for a 25-minute presentation, followed by a 25-minute breakout question-and-answer session.

A webcast of Quality Systems' audio presentation will be available on Monday, May 14, 2011 (beginning at the start time of the presentation) and can be viewed by accessing http://wsw.com/webcast/jmp17/qsii/. It will be archived for 90 days.

San Francisco-based JMP Securities is a full-service investment bank that provides equity research, institutional brokerage and investment banking services to public and private growth companies and their investors. The firm is a subsidiary of publicly traded JMP Group Inc. (NYSE:JMP). For more information, go to www.jmpsecurities.com.

About Quality Systems, Inc.

Irvine, Calif.-based Quality Systems, Inc. and its NextGen Healthcare subsidiary develop and market computer-based practice management, electronic health records and revenue cycle management applications as well as connectivity products and services for medical and dental group practices and small hospitals. Visit www.qsii.com and www.nextgen.com for additional information.


This news release may contain forward-looking statements within the meaning of the federal securities laws. Statements regarding future events, developments, the Company's future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future (including, without limitation, statements concerning revenue and net income), are forward-looking statements within the meaning of these laws and involve a number of risks and uncertainties. Management believes that these forward looking statements are reasonable and are based on reasonable assumptions and forecasts, however, undue reliance should not be placed on such statements that speak only as of the date hereof. Moreover, these forward-looking statements are subject to a number of risks and uncertainties, some of which are outlined below. As a result, actual results may vary materially from those anticipated by the forward-looking statements. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are: the volume and timing of systems sales and installations; length of sales cycles and the installation process; the possibility that products will not achieve or sustain market acceptance; seasonal patterns of sales and customer buying behavior; impact of incentive payments under The American Recovery and Reinvestment Act on sales and the ability of the Company to meet continued certification requirements; the development by competitors of new or superior technologies; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; undetected errors or bugs in software; product liability; changing economic, political or regulatory influences in the health-care industry; changes in product-pricing policies; availability of third-party products and components; competitive pressures including product offerings, pricing and promotional activities; the Company's ability or inability to attract and retain qualified personnel; possible regulation of the Company's software by the U.S. Food and Drug Administration; uncertainties concerning threatened, pending and new litigation against the Company including related professional services fees; uncertainties concerning the amount and timing of professional fees incurred by the Company generally; changes of accounting estimates and assumptions used to prepare the prior periods' financial statements; general economic conditions; and the risk factors detailed from time to time in the Company's periodic reports and registration statements filed with the Securities and Exchange Commission. A significant portion of the Company's quarterly sales of software product licenses and computer hardware is concluded in the last month of the fiscal quarter, generally with a concentration of such revenues earned in the final ten business days of that month. Due to these and other factors, the Company's revenues and operating results are very difficult to forecast. A major portion of the Company's costs and expenses, such as personnel and facilities, are of a fixed nature and, accordingly, a shortfall or decline in quarterly and/or annual revenues typically results in lower profitability or losses. As a result, comparison of the Company's period-to-period financial performance is not necessarily meaningful and should not be relied upon as an indicator of future performance. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.

Quality Systems, Inc.
Susan J. Lewis, 303-804-0494

© Business Wire 2012
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on QUALITY SYSTEMS, INC.
10/15 NEXTGEN HEALTHCARE : to Help Clients Transition to Value-Based Care and MACRA Fi..
10/12 QUALITY SYSTEMS, INC. : to Host Fiscal 2017 Second Quarter Results Conference Ca..
08/30 QUALITY SYSTEMS, INC. : to Present at the Robert W. Baird 2016 Healthcare Confer..
08/26 QUALITY : $12,990 Federal Contract Awarded to Ace Technology Partners
08/18 QUALITY SYSTEMS, INC : Change in Directors or Principal Officers, Submission of ..
07/29 QUALITY SYSTEMS : reports 1Q loss
07/28 QUALITY SYSTEMS, INC : Results of Operations and Financial Condition, Financial ..
07/28 QUALITY SYSTEMS, INC. : Reports Fiscal 2017 First Quarter Results
07/25 QUALITY SYSTEMS, INC. : to Host Fiscal 2017 First Quarter Results Conference Cal..
More news
Sector news : IT Services & Consulting - NEC
10/24DJTata Sons Unexpectedly Removes Mistry as Chairman
10/21DJCyberattack Knocks Out Access to Websites
10/20DJEU Court Adviser Backs Intel Appeal Over $1.17 Billion Fine
10/20 WIPRO : India's Wipro to buy U.S. cloud services company Appirio for $500 millio..
10/18DJSalesforce's M&A Target List Excluded Twitter
More sector news : IT Services & Consulting - NEC
News from SeekingAlpha
10/17 Midday Gainers / Losers
10/14 After Hours Gainers / Losers
07/30 Quality Systems' (QSII) CEO Rusty Frantz on Q1 2017 Results - Earnings Call T..
07/28 Quality Systems misses by $0.03, misses on revenue
Financials ($)
Sales 2017 500 M
EBIT 2017 65,2 M
Net income 2017 28,7 M
Debt 2017 29,7 M
Yield 2017 -
P/E ratio 2017 25,06
P/E ratio 2018 20,69
EV / Sales 2017 1,52x
EV / Sales 2018 1,37x
Capitalization 729 M
More Financials
Duration : Period :
Quality Systems, Inc. Technical Analysis Chart | QSII | US7475821044 | 4-Traders
Full-screen chart
Technical analysis trends QUALITY SYSTEMS, ...
Short TermMid-TermLong Term
Technical analysis
Income Statement Evolution
More Financials
Mean consensus HOLD
Number of Analysts 15
Average target price 12,7 $
Spread / Average Target 6,9%
Consensus details
EPS Revisions
More Estimates Revisions
John R. Frantz President, Chief Executive Officer & Director
Jeffrey H. Margolis Chairman
Daniel J. Morefield Chief Operating Officer & Executive Vice President
James R. Arnold Chief Financial Officer
David A. Metcalfe Chief Technology Officer & Executive VP
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ACCENTURE PLC10.61%75 211
INFOSYS LTD-6.28%35 451
NETEASE INC (ADR)45.40%34 648
VMWARE, INC.28.88%30 944
More Results